Simon Sturge
Chairman at MOONLAKE IMMUNOTHERAPEUTICS
Net worth: 14 M $ as of 2024-04-29
Network origin in Simon Sturge first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
49
| Public Company | Pharmaceuticals: Major | 49 |
University of Sussex
25
| College/University | Other Consumer Services | 25 |
Weizmann UK
 Weizmann UK Miscellaneous Commercial ServicesCommercial Services Weizmann UK is a non-profit company that operates scientific research institutes. The company is based in London, UK. The British company was founded in 1950.
19
| Non-Profit Organization | Miscellaneous Commercial Services | 19 |
18
| Public Company | Biotechnology | 18 |
| Public Company | Pharmaceuticals: Major | 15 | |
13
| Public Company | Packaged Software | 13 |
| Public Company | Miscellaneous Commercial Services | 11 | |
Mediar Therapeutics, Inc.
 Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA.
10
| Holding Company | Biotechnology | 10 |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Simon Sturge via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Masters Business Admin Undergraduate Degree Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Executive Officer | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
Sareum Ltd.
 Sareum Ltd. Drugstore ChainsRetail Trade Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK | Drugstore Chains | Director/Board Member Director/Board Member | |
| SANOFI | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Deutsche Akademie der Technikwissenschaften eV
 Deutsche Akademie der Technikwissenschaften eV Miscellaneous Commercial ServicesCommercial Services Deutsche Akademie der Technikwissenschaften eV advises on technical and technological issues for engineering and applied sciences. The private company is based in Munich, Germany. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
ImmunOs Therapeutics AG
 ImmunOs Therapeutics AG BiotechnologyHealth Technology ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith. | Biotechnology | Director/Board Member Director/Board Member | |
Verband der Chemischen Industrie eV
 Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Private Equity Investor Chief Tech/Sci/R&D Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin | |
| BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Undergraduate Degree | |
| Technische Universität Darmstadt | College/University | Doctorate Degree Masters Business Admin | |
| ABLYNX | Biotechnology | Investor Relations Contact Director/Board Member | |
| Ghent University | College/University | Graduate Degree Graduate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President | |
Philips Healthcare
 Philips Healthcare Medical SpecialtiesHealth Technology Philips Healthcare engages in the manufacture of electromedical apparatus. It develops products that offer added value to the entire care cycle: from disease prevention to screening, diagnosis, treatment and follow-up care at home or in hospital. It also deals with cardiology, oncology, and women's health. It focuses on serious health problems, which people are confronted, such as heart problems, lung and breast disease. The company is headquartered in Eindhoven, the Netherlands. | Medical Specialties | Corporate Officer/Principal Sales & Marketing | |
Feedback Medical Ltd.
 Feedback Medical Ltd. Packaged SoftwareTechnology Services Part of Feedback Plc, Feedback Medical Ltd. develops medical imaging software. The company is based in London, UK. Thomas James Oakley has been the CEO of the British company since 2019. Feedback Medical was acquired by Feedback Plc on May 19, 2014 for $0.35 million. | Packaged Software | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
PA Consulting Group Ltd.
 PA Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services PA Consulting Group Ltd. engages in the provision of management, systems, technology consulting, and innovation services. The company was founded by Ernest Button on September 3, 2015 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree | |
| Trinity College Dublin | College/University | Undergraduate Degree Graduate Degree | |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Graduate Degree Doctorate Degree | |
| SAREUM HOLDINGS PLC | Miscellaneous | Chairman Director/Board Member | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| University of Glasgow | College/University | Doctorate Degree Undergraduate Degree | |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| University of Groningen | College/University | Doctorate Degree Undergraduate Degree | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Yale University | College/University | Graduate Degree Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Moonlake Immunotherapeutics Ltd. | Director/Board Member Chief Tech/Sci/R&D Officer | ||
Cristal Delivery BV
 Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Ovarian Cancer Action
 Ovarian Cancer Action Miscellaneous Commercial ServicesCommercial Services Ovarian Cancer Action is a non-profit organization which supports women who are affected by ovarian cancer. The company was founded by Allyson Kaye in 2005 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| The University of Colorado | College/University | Undergraduate Degree Corporate Officer/Principal | |
Redalpine Venture Partners AG
 Redalpine Venture Partners AG Investment ManagersFinance Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006. | Investment Managers | Private Equity Analyst | |
GH Research Ireland Ltd.
 GH Research Ireland Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, GH Research Ireland Ltd. is an Irish clinical-stage biopharmaceutical company that develops innovative therapies for the treatment of mental illnesses. The company is based in Dublin, Ireland and is a subsidiary of GH Research Plc. | Miscellaneous Commercial Services | Director/Board Member | |
| GH RESEARCH PLC | Pharmaceuticals: Major | Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
| ALMIRALL, S.A. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
| United States | 16 |
| United Kingdom | 13 |
| Germany | 7 |
| Belgium | 6 |
| Netherlands | 5 |
Sectoral
| Health Technology | 21 |
| Consumer Services | 15 |
| Commercial Services | 10 |
| Finance | 3 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 401 |
| Corporate Officer/Principal | 153 |
| Chairman | 103 |
| Independent Dir/Board Member | 71 |
| Chief Executive Officer | 61 |
Most connected contacts
| Insiders | |
|---|---|
| Peter D. Parker | 34 |
| Stephen Parker | 34 |
| Karl-Ludwig Kley | 32 |
| Catherine Moukheibir | 29 |
| Timothy Irish | 29 |
| David Skok | 26 |
| Maina Bhaman | 26 |
| Alastair Riddell | 24 |
| David Chiswell | 23 |
| Jérôme Contamine | 23 |
| Andrew Phillips | 23 |
| Shamshad Akhtar | 20 |
| Daniel O'Day | 19 |
| John Henry Ritblat | 19 |
| Lena Elisabeth Svanberg | 16 |
- Stock Market
- Insiders
- Simon Sturge
- Company connections
